FDA Approved: OLMESARTAN MEDOXOMIL — Supplemental Application (ScieGen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for olmesartan medoxomil from ScieGen Pharmaceuticals, enabling marketing of a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

SUPPL AP for OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL)